المؤلفون: Nemati, Mohammadmahdi, Ahmadi, Ahmadreza, Hashemzehi, Ahmad, Nasrullozoda, Farukhruzi, Abedi, Mohsen, Hashemzaei, Masoud^{Aff1, IDs10989023105827_cor6}

المصدر: International Journal of Peptide Research and Therapeutics: formerly known as "Letters in Peptide Science". 30(1)

المؤلفون: Yoshio, Taku^Aff2, Okamoto, Hiroshi^Aff3

المساهمون: Hirohata, Shunsei, editor^Aff1

المصدر: Neuropsychiatric Systemic Lupus Erythematosus : Pathogenesis, Clinical Aspects and Treatment. :155-168

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Lenert A, Niewold TB, Lenert P

المصدر: Drug Design, Development and Therapy, Vol Volume11, Pp 747-757 (2017)

مصطلحات موضوعية: BAFF, APRIL, Lupus, B cells, Blisibimod, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/spotlight-on-blisibimod-and-its-potential-in-the-treatment-of-systemic-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881

URL الوصول: https://doaj.org/article/6bf71f051d90440b8e61b6cbc4aacaec

المؤلفون: Joyce S Hui-Yuen, Ayse Bag-Ozbek

المصدر: Therapeutics and Clinical Risk Management

مصطلحات موضوعية: Review, epratuzumab, 030204 cardiovascular system & hematology, Ofatumumab, Atacicept, 03 medical and health sciences, chemistry.chemical_compound, rituximab, 0302 clinical medicine, systemic lupus erythematosus, Blisibimod, immune system diseases, medicine, Pharmacology (medical), 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, skin and connective tissue diseases, Chemical Health and Safety, treatment, business.industry, General Medicine, medicine.disease, Belimumab, Tabalumab, chemistry, Immunology, Rituximab, Ocrelizumab, novel B-cell therapies, belimumab, business, Safety Research, Epratuzumab, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9c20f95497b95456683c6fd090e6ea0
https://doi.org/10.2147/tcrm.s252592

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Petar Lenert, Timothy B. Niewold, Aleksander Lenert

المصدر: Drug Design, Development and Therapy

مصطلحات موضوعية: 0301 basic medicine, medicine.drug_class, Recombinant Fusion Proteins, Pharmaceutical Science, Review, Monoclonal antibody, blisibimod, 03 medical and health sciences, 0302 clinical medicine, Blisibimod, immune system diseases, Drug Discovery, B-Cell Activating Factor, medicine, Clinical endpoint, Humans, Lupus Erythematosus, Systemic, Avidity, APRIL, B-cell activating factor, skin and connective tissue diseases, 030203 arthritis & rheumatology, Pharmacology, B cells, Systemic lupus erythematosus, business.industry, lupus, medicine.disease, Belimumab, 030104 developmental biology, Tolerability, Immunology, BAFF, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb5ab995504fd7b144df435e93e193b
http://europepmc.org/articles/PMC5357079

المؤلفون: Meng-Jun, Tao, Ping, Cheng, Lai-Run, Jin, Jun, Zhou, Wei, Shi, Hui, Peng, Liang, Xu, Zhi, Li, Hui, Yuan

المصدر: Pakistan Journal of Medical Sciences

مصطلحات موضوعية: Biologic agents, Epratuzumab, Original Research/Meta Analysis, SLE, Tabaluma, Blisibimod, Network meta-analysis, Rituximab, Belimumab, Atacicept

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::a7b8216b3f5e1c9a717d3fb5d3ea826a
https://pubmed.ncbi.nlm.nih.gov/31777515

المؤلفون: Hui Peng, Meng-Jun Tao, Zhi Li, Jun Zhou, Lai-Run Jin, Wei Shi, Ping Cheng, Hui Yuan, Liang Xu

المصدر: Pakistan Journal of Medical Sciences. 35

مصطلحات موضوعية: 030203 arthritis & rheumatology, 0301 basic medicine, medicine.medical_specialty, business.industry, General Medicine, Cochrane Library, medicine.disease, Belimumab, Atacicept, Tabalumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Blisibimod, Internal medicine, Meta-analysis, medicine, Rituximab, business, Epratuzumab, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6fec855a9f86d8f7c9d4be0e78096fb0
https://doi.org/10.12669/pjms.35.6.771

المؤلفون: K Argunova

المصدر: Clinical Medicine and Pharmacology. :32-36

مصطلحات موضوعية: medicine.medical_specialty, Blisibimod, business.industry, Rheumatoid arthritis, medicine, General Medicine, Differential diagnosis, medicine.disease, business, Dermatology, Anti-SSA/Ro autoantibodies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e8796ac917e0ba525c4ca0a1f2d2dbff
https://doi.org/10.12737/article_59b7a6aa9d2193.01248876